Sequenom Inc's

Name: Sequenom Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SQNM Sales vs. its Competitors Q4 2016

Comparing the current results to its competitors, Sequenom Inc reported Revenue decrease in the 4 quarter 2016 year on year by -10.62 %, slower than the combined decrease of the SQNM's competitors by -10.63 %, recorded in the same quarter.

• List of SQNM Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Sequenom Inc recorded a net loss, as well as most of its competitors.

<< SQNM Stock Performance Comparisons

<< See the full list of SQNM competitors

Overall company Market Share Q4 2016

despite revenue deterioration, Sequenom Inc increased its market share in this segment. company improved its market share in this segment. << More on SQNM Market Share.

*Market share is calculated based on total revenue.

SQNM's Stock Performance relative to its Competitors

Publicly Traded Peers of Sequenom Inc

Manhattan Scientifics Inc
Share Performance

0.00%

30 Days

Manhattan Scientifics Inc

Profile

Manhattan Scientifics Inc is a technology-focused company that operates on a licensing business model. They acquire and develop innovative technologies in the fields of medicine, energy, and nanotechnology, and then license these technologies to companies for further development and commercialization. By leveraging their intellectual property portfolio, Manhattan Scientifics Inc generates revenue through licensing agreements and strategic partnerships.

More about Manhattan Scientifics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 0.056 mill.	$ - mill.	$ -1.056 mill.

Sources: Sequenom Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 5:02 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sequenom Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.